Device recall · June 10, 2020
Medtronic Implantable Insulin Pump System recall
Why: Internal testing results showed endotoxin-related test result did not meet specifications for implantable insulin pump. If pumps have higher than allowed endotoxin levels, patients may have an effect of fever, hypotension, anaphylactic shock, hyperglycemia, or diabetic ketoacidosis (DKA), potentially followed by secondary multi-organ failure (primarily renal and hepatic) and/or death.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Medtronic Implantable Insulin Pump System, REF: MMT-2007D, Sterile EO, CE 0459 UDI: 00763000043001
- Lots / codes
Device not distributed within the US. All Pump lots produced May 21, 2019 to present containing the following serial numbers: 31359, 31360, and 31332
- Quantity
- 24 Pumps
- Company
- Medtronic Inc., Northridge, CA
- Distribution
- No US Distribution. OUS: Netherlands, France, and Sweden
- Initiated
- April 10, 2020 · Voluntary: Firm initiated
- Classified
- June 2, 2020
- Reported
- June 10, 2020
- Ended
- April 27, 2021
- How notified
- Telephone
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.